组织芯片

乳腺癌组织芯片，不与BRC711重复，49例，49芯，包括正常/良性 和癌组织 提供分级，TNM分期，和AR，ER，PR，HER2，P53，EGFR，Ki67 IHC数据。

芯片编号	CR-XBRC491
芯片名称	BRC491乳腺癌，49例，49芯（2.0mm）
芯片说明	乳腺癌组织芯片，不与BRC711重复，49例，49芯，包括正常/良性 和癌组织 提供分级，TNM分期，和AR，ER，PR，HER2，P53，EGFR，Ki67 IHC数据。
点数:	49芯
例数:	49例
组织固定方式:	福尔马林固定24h
QA/QC:	HE染色和IHC染色
应用:	常规组织学操作包括免疫组织化学(IHC)和原位杂交(ISH)，可以在我们的技术支持页面找到操作流程。
注意事项:	1.收到产品后请常温保存，并在24个月内使用，2.请在实验前60°烤片30分钟，3.请选择温和的修复方式，以免造成组织脱落。
位置	年龄	性别	标本部位	病理分类	病理分级	TNM_T	TNM_N	TNM_M	备注
A1	28	F	乳腺，Breast	导管原位癌；Ductal carcinoma in situ		Tis	N0	M0
A2	63	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T4	N3	M0
A3	43	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N0	M0
A4	74	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
A5	60	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T4	N3	M0
A6	49	F	乳腺，Breast	乳头状腺癌；Papillary carcinoma	II	Tis	N0	M0
B1	41	F	乳腺，Breast	导管原位癌；Ductal carcinoma in situ	I	Tis	N0	M0
B2	43	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
B3	44	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N1	M0
B4	50	F	乳腺，Breast	导管原位癌；Ductal carcinoma in situ		Tis	N0	M0
B5	62	F	乳腺，Breast	浸润性小叶癌；Invasive lobular carcinoma	I	T3	N1	M0
B6	54	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N1	M0
C1	43	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	I~II	T2	N1	M0
C2	48	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N1	M0
C3	40	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N0	M0
C4	50	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
C5	35	F	乳腺，Breast	浸润性小叶癌；Invasive lobular carcinoma	I	T2	N0	M0
C6	92	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T4	N1	M0
D1	41	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N1	M0
D2	30	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
D3	28	F	乳腺，Breast	浸润性小叶癌；Invasive lobular carcinoma	I~II	T2	N1	M0
D4	42	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N0	M0
D5	50	F	乳腺，Breast	浸润性小叶癌；Invasive lobular carcinoma	I	T4	N1	M0
D6	68	F	乳腺，Breast	浸润性小叶癌；Invasive lobular carcinoma	II~III	T4	N1	M0
E1	64	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N0	M0
E2	56	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N0	M0
E3	50	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T3	N0	M0
E4	50	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T3	N3	M0
E5	65	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N0	M0
E6	50	F	乳腺，Breast	导管原位癌；Ductal carcinoma in situ	I	Tis	N0	M0
F1	47	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T3	N2	M0
F2	53	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N1	M0
F3	51	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T4	N0	M0
F4	44	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N0	M0
F5	45	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N1	M0
F6	51	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	I~II	T2	N1	M0
G1	33	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N0	M0
G2	42	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N1	M0
G3	48	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N1	M0
G4	61	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T3	N1	M0
G5	37	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N0	M0
G6	44	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	I	T2	N1	M0
H1	55	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N0	M0
H2	31	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N1	M0
H3	46	F	乳腺，Breast	浸润性小叶癌；Invasive lobular carcinoma	I	T3	N1	M0
H4	36	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N1	M0
H5	57	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N1	M0
H6	52	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T3	N1	M0
I1	37	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma		T2	N0	M0